13F

Stock

Vivos Therapeutics, Inc.

VVOS · held by 20 managers

Reported value

$1.34M

Holders

20

+0 new · −0 exited

Holders’ est. mark

−$134

Price effect on 2 books still in the name

Largest holder

$617.4K

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard304.2K$617.4KHeld
DRW Securities, LLC115.9K$235.3KHeld
GEODE CAPITAL MANAGEMENT, LLC56.3K$114.3KHeld
B. Riley Wealth Advisors, Inc.43.5K$88.4KHeld
COMMONWEALTH EQUITY SERVICES, LLC40.5K$82.2KHeld
BlackRock, Inc.27.8K$56.5KHeld
State Street24.9K$50.6KHeld
Acorn Wealth Advisors, LLC14.8K$30KHeld
UBS Group AG12.7K$25.7KHeld
NORTHERN TRUST CORP12.5K$25.4KHeld
Tower Research Capital LLC (TRC)2.96K$6.02KHeld
OSAIC HOLDINGS, INC.1.14K$2.32KHeld
SIGNATUREFD, LLC547$1.11KHeld
Blue Trust, Inc.160$325Held
BANK OF AMERICA CORP /DE/132$267−$126Cut−$96
Kozak & Associates, Inc.49$101Held
Global Retirement Partners, LLC23$47Held
MORGAN STANLEY7$14−$8Cut−$3.29K
CITIGROUP INC1$2Held
ROYAL BANK OF CANADA4$0Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.